Home › Overweight › Kentucky › Louisville
Overweight clinical trials in Louisville, KY
15 studies for Overweight are looking for participants at sites in and around Louisville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
RecruitingPhase 2
- L-MARC Research Center /ID# 282008, Louisville
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RecruitingPhase 3
- Monroe Biomedical Research, Louisville
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
- Monroe Biomedical Research - Louisville, Louisville
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RecruitingPhase 3
- Norton Children's Endocrinology, Louisville
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RecruitingPhase 3
- Gastroenterology Health Partners, Louisville
- Gastroenterology Health Partners, New Albany · 4 mi away
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RecruitingPhase 3
- Gastroenterology Health Partners, Louisville
- Gastroenterology Health Partners, New Albany · 4 mi away
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
RecruitingPhase 3
- Monroe Biomedical Research - Louisville, Louisville
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- Monroe Biomedical Research - Louisville, Louisville
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
RecruitingPhase 3
- Monroe Biomedical Research, Louisville
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
RecruitingPhase 3
- L-MARC Research Center, Louisville
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- Monroe Biomedical Research - Louisville, Louisville
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RecruitingPhase 3
- Monroe Biomedical Research, Louisville
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
RecruitingPhase 3
- Monroe Biomedical Research, LLC, Louisville
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
RecruitingPhase 3
- ACCOMPLISH-1 Research Site, Louisville
A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
RecruitingPhase 2
- Monroe Biomedical Research, Louisville
Overweight trials in other cities
- Houston, TX33 studies
- San Antonio, TX33 studies
- Chicago, IL28 studies
- Orlando, FL25 studies
- Miami, FL23 studies
- Las Vegas, NV23 studies
- Dallas, TX20 studies
- Atlanta, GA20 studies
- New York City, NY19 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- Austin, TX18 studies
Other studies in Louisville
- Non-Small Cell Lung Cancer23 studies
- Obesity17 studies
- Cancer (all types)14 studies
- Heart Failure13 studies
- Multiple Myeloma12 studies
- Acute Myeloid Leukemia12 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Ovarian Cancer12 studies
- Breast Cancer11 studies
- Lung Cancer11 studies
- Ulcerative Colitis10 studies
- Prostate Cancer10 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.